Cargando…
Uncertainties in Screening and Prevention of Group B Streptococcus Disease
In autumn 2016, the UK Department of Health (now Department of Health and Social Care) convened 2 meetings to discuss how to address research evidence gaps in order to minimize the impact of infant group B streptococcus (GBS) disease in the United Kingdom. At that meeting, a number of research prior...
Autores principales: | Le Doare, Kirsty, Heath, Paul T, Plumb, Jane, Owen, Natalie A, Brocklehurst, Peter, Chappell, Lucy C |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6669315/ https://www.ncbi.nlm.nih.gov/pubmed/30561556 http://dx.doi.org/10.1093/cid/ciy1069 |
Ejemplares similares
-
A Vaccine Against Group B Streptococcus: Recent Advances
por: Carreras-Abad, Clara, et al.
Publicado: (2020) -
20 million pregnant women with group B streptococcus carriage: consequences, challenges, and opportunities for prevention
por: Paul, Proma, et al.
Publicado: (2023) -
Anti-Group B Streptococcus antibody in infants born to mothers with human immunodeficiency virus (HIV) infection()
por: Le Doare, Kirsty, et al.
Publicado: (2015) -
Risk factors for Group B Streptococcus colonisation and disease in Gambian women and their infants
por: Le Doare, K., et al.
Publicado: (2016) -
The Italian arm of the PREPARE study: an international project to evaluate and license a maternal vaccine against group B streptococcus
por: Berardi, Alberto, et al.
Publicado: (2020)